PHR — Pharmena SA Share Price
0.000.00%
Last trade - 00:00- PLN75.51m
- PLN53.16m
- PLN0.30m
- 74
- 72
- 52
- 76
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.35 | ||
| Price to Tang. Book | 3.37 | ||
| Price to Free Cashflow | 2.31 | ||
| Price to Sales | 252.56 | ||
| EV to EBITDA | 1.6 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 147.31% | ||
| Return on Equity | 336.97% | ||
| Operating Margin | 11016.39% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | PLNm | 11.1 | 9.93 | 15.21 | 0.3 | 0.3 | n/a | n/a | -53% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.
Directors
- Konrad Palka CMG
- Marzena Wieczorkowska VMG
- Katarzyna Konopacka CAO
- Jan Adamus SUB
- Jacek Dauenhauer SUB
- Agnieszka Dziki SUB
- Anna Janicka SUB
- Zbigniew Molenda SUB
- Anna Sysa-Jedrzejowska SUB
- Jacek Szwajcowski SUB
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 17th, 2008
- Public Since
- August 25th, 2008
- No. of Employees
- 15
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- Warsaw Stock Exchange
- Shares in Issue
- 11,137,758
- Address
- ul. Wolczanska 178, LODZ, 90-530
- Web
- https://www.pharmena.eu/
- Phone
- +48 422913370
- Contact
- Magdalena Michalewska
- Auditors
- PKF Consult Sp. z o.o.
Upcoming Events for PHR
Pharmena SA Annual Shareholders Meeting
Q2 2024 Pharmena SA Earnings Release
Similar to PHR
4Mass SA
Warsaw Stock Exchange
Auxilia SA
Warsaw Stock Exchange
Delko SA
Warsaw Stock Exchange
Dr Miele Cosmed SA
Warsaw Stock Exchange
Euro-Tax pl SA
Warsaw Stock Exchange
FAQ
What is the Pharmena SA share price?
As of Today at 19:17 UTC, shares in Pharmena SA are trading at PLN6.78. This share price information is delayed by 15 minutes.
How has the Pharmena SA share price performed this year?
Shares in Pharmena SA last closed at PLN6.78 and the price had moved by +1.19% over the past 365 days. In terms of relative price strength the Pharmena SA share price has underperformed the FTSE Global All Cap Index by -5% over the past year.
What are the analyst and broker recommendations for Pharmena SA?
There is no consensus recommendation for this security.
What is the Pharmena SA dividend yield?
Pharmena SA does not currently pay a dividend.
Does Pharmena SA pay a dividend?
Pharmena SA does not currently pay a dividend.
When does Pharmena SA next pay dividends?
Pharmena SA does not currently pay a dividend.
How do I buy Pharmena SA shares?
To buy shares in Pharmena SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Pharmena SA?
As of the previous close price of PLN6.78, shares in Pharmena SA had a market capitalisation of PLN75.51m.
Where are Pharmena SA shares listed?
Here are the trading details for Pharmena SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: PHR
What kind of share is Pharmena SA?
Based on an overall assessment of its quality, value and momentum Pharmena SA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Pharmena SA share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Pharmena SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pharmena SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -4.57%.
As of the last closing price of PLN6.78, shares in Pharmena SA were trading -1.14% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Pharmena SA PE Ratio?
The Pharmena SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at PLN6.78.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Pharmena SA?
Pharmena SA's management team is headed by:
- Konrad Palka - CMG
- Marzena Wieczorkowska - VMG
- Katarzyna Konopacka - CAO
- Jan Adamus - SUB
- Jacek Dauenhauer - SUB
- Agnieszka Dziki - SUB
- Anna Janicka - SUB
- Zbigniew Molenda - SUB
- Anna Sysa-Jedrzejowska - SUB
- Jacek Szwajcowski - SUB